Cargando…
Response to comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734048/ https://www.ncbi.nlm.nih.gov/pubmed/31516832 http://dx.doi.org/10.1016/j.ymgmr.2019.100511 |
| _version_ | 1783450082608152576 |
|---|---|
| author | Wolf, Barry |
| author_facet | Wolf, Barry |
| author_sort | Wolf, Barry |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6734048 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67340482019-09-12 Response to comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” Wolf, Barry Mol Genet Metab Rep Letter to the Editor Elsevier 2019-09-06 /pmc/articles/PMC6734048/ /pubmed/31516832 http://dx.doi.org/10.1016/j.ymgmr.2019.100511 Text en © 2019 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Wolf, Barry Response to comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
| title | Response to comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
| title_full | Response to comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
| title_fullStr | Response to comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
| title_full_unstemmed | Response to comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
| title_short | Response to comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” |
| title_sort | response to comment on “high doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: implications for individuals with biotin-responsive inherited metabolic disorders” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734048/ https://www.ncbi.nlm.nih.gov/pubmed/31516832 http://dx.doi.org/10.1016/j.ymgmr.2019.100511 |
| work_keys_str_mv | AT wolfbarry responsetocommentonhighdosesofbiotincaninterferewithimmunoassaysthatusebiotinstreptavidintechnologiesimplicationsforindividualswithbiotinresponsiveinheritedmetabolicdisorders |